Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma

Filippo Spriano, Elaine Y. Chung, Nicolo’ Panini, Luciano Cascione, Andrea Rinaldi, Eugenio Erba, Anastasios Stathis, Maurizio D'Incalci, Francesco Bertoni, Raffaella Gatta

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1022-1025
Number of pages4
JournalBritish Journal of Haematology
Volume184
Issue number6
DOIs
Publication statusPublished - Mar 2019

Keywords

  • BCL6
  • FLI1
  • chemotherapy
  • diffuse large B cell lymphoma
  • lymphomas

ASJC Scopus subject areas

  • Hematology

Cite this

Spriano, F., Chung, E. Y., Panini, N., Cascione, L., Rinaldi, A., Erba, E., ... Gatta, R. (2019). Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma. British Journal of Haematology, 184(6), 1022-1025. https://doi.org/10.1111/bjh.15212